Stay updated on Ublituximab in RMS: Clinical Trial
Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.

Latest updates to the Ublituximab in RMS: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 added; previous notice about government funding lapse (v3.4.1) removed. These changes affect only site maintenance and operate-status messaging, not trial data, eligibility, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedFunding-status notice appears at the top of the page and the site revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates were made: a glossary display option was added, and new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were introduced, along with a revision identifier 'v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedA consolidated 'Locations' section lists participating states (Arizona, Colorado, Florida, Kentucky, Missouri, Nevada, New Jersey, New Mexico, New York, Ohio, Pennsylvania, Texas, Washington) and the prior state-specific location subsections were removed, restructuring how trial sites are presented.SummaryDifference1%

- Check92 days agoChange DetectedPublications note updated to indicate items are automatically filled in from PubMed and that PubMed is a public database; Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Ublituximab in RMS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.